AcusMu Medtech Co. Ltd
Update：2026/09/15
Industries
Main Industry
Health Care
Main Product/Service
Microneedle Patch. AcusMu Medtech Co. Ltd (Acus: Needle, Mu: Micro in Latin) is a professional medical technology company specializing in transdermal delivery. Our microneedle technology can effectively deliver functional ingredients through the skin and into the human body. Leveraging precise manufacturing processes and proprietary formulations, we transform cosmetics, skincare products, and pharmaceuticals into convenient and comfortable transdermal delivery products. In our initial startup phase, we entered the market through beauty and skincare products, first developing three targeted skincare products—anti-acne, spot-fading, and anti-wrinkle—to overcome the bottleneck of conventional commercial skincare products, where functional ingredients fail to be effectively absorbed through the skin.
(The content above was translated by AI.)
(The content above was translated by AI.)
Founded Year
2022
Unified Business No.
90144886
Status
Active
Number of Employees
2
Total Paid-in
Capital
2,153,505 (NT$)
Location of Company
Taiwan
, Taipei City
Overseas Development
United States of America
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Microneedle technology was listed as one of the top ten emerging technologies of 2020 by the American monthly magazine *Scientific American*, possessing novel innovation and poised to exert a significant impact in the future. Our company was established in May 2022 as a technology startup spun off from the research and development achievements of National Taipei University of Technology. The core technology and patented formulas originate from the years of research and development results of Professor Kuo-Yuan Hwa's team at National Taipei University of Technology.
Our microneedle technology can effectively deliver functional ingredients through the skin into the human body, overcoming the bottleneck of traditional transdermal delivery's inability to penetrate the epidermal barrier. The company's founders and team recognized the future market potential of microneedle technology. Coupled with early-stage investments from external investors and the participation of dermatologists in clinical testing, this inspired the motivation to start the business.
During the early stages of our venture, we completed laboratory pilot production, engineering verification, and clinical validation. In addition to being selected for the Ministry of Economic Affairs' 2023 SelectUSA subsidy program, we also received the Taipei City Industry Development Entrepreneurship Subsidy.
Our mission is to utilize our proprietary formulas and precise manufacturing processes to transform cosmetics and pharmaceuticals into convenient, comfortable, portable, easy-to-store, and highly efficient transdermal delivery products in a convenient and comfortable manner.
(The content above was translated by AI.)
Our microneedle technology can effectively deliver functional ingredients through the skin into the human body, overcoming the bottleneck of traditional transdermal delivery's inability to penetrate the epidermal barrier. The company's founders and team recognized the future market potential of microneedle technology. Coupled with early-stage investments from external investors and the participation of dermatologists in clinical testing, this inspired the motivation to start the business.
During the early stages of our venture, we completed laboratory pilot production, engineering verification, and clinical validation. In addition to being selected for the Ministry of Economic Affairs' 2023 SelectUSA subsidy program, we also received the Taipei City Industry Development Entrepreneurship Subsidy.
Our mission is to utilize our proprietary formulas and precise manufacturing processes to transform cosmetics and pharmaceuticals into convenient, comfortable, portable, easy-to-store, and highly efficient transdermal delivery products in a convenient and comfortable manner.
(The content above was translated by AI.)
